Efficacy and safety of electromagnetic acupuncture using electromagnetic therapy stimulator(Whata153) for the treatment of chronic low back pain

Efficacy and safety of electromagnetic acupuncture using electromagnetic therapy stimulator(Whata153) for the treatment of chronic low back pain: Single center, Randomized, Parallel, Research clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002915

Enrollment

104

Registered

2018-06-05

Start date

2019-01-01

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Participants will be treated 6 sessions twice per week for 3weeks. Experimental group will receive acupunctrue with electromagnetic stimulator(whata153) and sham group will be perform

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria are: between 19–70 years of age; with chronic low back pain for more than 3 months duration; a minimum pain intensity score of 40-mm in the 100-mm visual analog scale; A participant who fully understands the trial procedure and the risks involved in taking it, is able to communicate with the examiner and follows the trial compliance; Agreeing to participate and signing informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria are: if they had previous spinal surgery; progressive neurological deficit or severe psychiatric or psychological disorders; serious spinal disorders, such as metastatic cancer, vertebral fracture, spinal infection and inflammatory spondylitis; may be unsuitable or unsafe for treatment, such as clotting disorders, taking anticoagulant agent, seizure disorders; using a device that may be affected by electromagnetic fields, such as a pacemaker or a hearing aid; taking medications that may affect clinical trials, such as corticosteroids and anticonvulsants, within the last week; pregnant, lactating or planning a pregnancy; participating in other clinical trials; deemed to be ineligible by a physician.

Design outcomes

Primary

Measure	Time frame
Visual analogue scale change	—

Secondary

Measure	Time frame
Visual analogue scale change;Oswestry Disability Index change	—

Countries

Korea, Republic of

Contacts

Public ContactJae-hui Kang

Daejeon University

rkd12@hanmail.net+82-41-521-7579

Outcome results